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Abstract
Bacterial pathogens that reside in membrane bound compartment manipulate the host cell machinery to establish and
maintain their intracellular niche. The hijacking of inter-organelle vesicular trafficking through the targeting of small
GTPases or SNARE proteins has been well established. Here, we show that intracellular pathogens also establish direct
membrane contact sites with organelles and exploit non-vesicular transport machinery. We identified the ER-to-Golgi
ceramide transfer protein CERT as a host cell factor specifically recruited to the inclusion, a membrane-bound compartment
harboring the obligate intracellular pathogen Chlamydia trachomatis. We further showed that CERT recruitment to the
inclusion correlated with the recruitment of VAPA/B-positive tubules in close proximity of the inclusion membrane,
suggesting that ER-Inclusion membrane contact sites are formed upon C. trachomatis infection. Moreover, we identified the
C. trachomatis effector protein IncD as a specific binding partner for CERT. Finally we showed that depletion of either CERT
or the VAP proteins impaired bacterial development. We propose that the presence of IncD, CERT, VAPA/B, and potentially
additional host and/or bacterial factors, at points of contact between the ER and the inclusion membrane provides a
specialized metabolic and/or signaling microenvironment favorable to bacterial development.
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Introduction
Chlamydia species are obligate intracellular Gram-negative
bacterial pathogens that infect genital, ocular and pulmonary
epithelial surfaces. Chlamydia are characterized by a biphasic
developmental cycle that occurs exclusively in the host cell. The
bacteria alternate between an infectious, metabolically inactive
form called elementary body (EB) that is characterized by a
condensed nucleoid, and an intracellular, metabolically active
form named reticulate body (RB). Once internalized, Chlamydia
resides in a membrane bound compartment, named the inclusion.
Shortly after uptake, an uncharacterized switch occurs leading to
the differentiation of EBs into RBs. The RBs then start to replicate
until the inclusion occupies a large part of the cytosol of the host
cell. Midway through, the developmental cycle becomes asyn-
chronous and RBs start to differentiate back into EBs. At the end
of the cycle, which last two to three days depending on the species,
EBs are released from the host cell allowing infection of
neighboring cells [1,2].
To establish and maintain their intracellular niche, Chlamydia
manipulate the host cellular machinery [3]. Once internalized
[4–6], Chlamydia directs the trafficking of the nascent inclusion to a
perinuclear localization via a mechanism involving microfilaments,
microtubules and the motor protein dynein [7]. The inclusion is
encased in a scaffold of host actin and intermediate filaments [8]
and infection induces Golgi fragmentation and formation of Golgi
ministacks that surround the inclusion [9]. ER tracks containing
Chlamydia antigens have also been described in the vicinity of the
inclusion membrane [10]. The inclusion does not interact with the
endocytic pathway [7,11], however it intercepts exocytic vesicles
and lipids from the Golgi [12]. Resident protein and lipid
constituents of multivesicular bodies are also delivered to Chlamydia
inclusion [13,14]. Some Rab GTPases are recruited to the
inclusion membrane [15], and host lipid droplets are targeted to
enhance intracellular survival and replication [16,17].
The secretion of Chlamydia effectors proteins is thought to be
important for a successful developmental cycle. To date, many
Chlamydia effector proteins have been identified. Some, but not all,
are type III secretion substrates and their function range from
entry to establishing and maintaining the replicative vacuole
[18,19]. Some of these effectors are released into the host cell
cytosol where they target cellular organelles or signaling pathways,
while others act directly at the inclusion membrane. C. trachomatis
encodes ,50 putative inclusion membrane proteins, including the
Inc proteins which are characterized by a large hydrophobic
domain of 40 or more amino acids. So far the inclusion membrane
localization of 22 of them has been confirmed [20] and only a few
of them have established functions [18]. IncA is involved in the
homotypic fusion of the C. trachomatis inclusions [21,22]. IncB,
CT101, CT222 and CT850 co-localized with activated Fyn and
Src kinases in inclusion membrane microdomains. These micro-
domains also interact with the centrosomes and it has been
proposed that these four inclusion proteins are involved in the
interaction of the inclusion with the microtubule network [23].
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dCT229 and CT813 have been assigned putative functions in
intercepting the host vesicular trafficking, based on their respective
interaction with the host proteins Rab4 [24] and VAMP7-8 [25].
Our knowledge of the cellular processes that are targeted by
Chlamydia has greatly increased over the past 10 years, but we have
only begun to identify the host and bacterial factors required for
bacterial development. To better understand the molecular
mechanisms underlying C. trachomatis infection, we recently
conducted an RNAi screen and identified CERT as a host factor
involved in C. trachomatis infection (I.D. and H.A., unpublished). In
non-infected cells, CERT is proposed to be involved in the non-
vesicular transfer of ceramide at ER-Golgi membrane contact sites
(MCSs). Ourresults indicate that ER-InclusionMCSs areformed in
C. trachomatis infected cells. We propose a model in which, through
IncD-dependent recruitment of CERT to the inclusion, C.
trachomatis exploit the non-vesicular lipid transport machinery of
the host cell and generate platforms specialized in metabolism and/
or signaling events favorable to its replication and development.
Results
CERT and VAPB localize to C. trachomatis inclusion
We recently conducted an RNAi screen and identified CERT as
a host factor involved in C. trachomatis infection (I.D. and H.A.,
unpublished). CERT is proposed to be a functional component of
ER-Golgi membrane contact sites (MCSs) (i.e. zone of close
apposition (10–50 nm) between two organelles [26,27]) involved in
the non-vesicular transfer of ceramide from the ER to the Golgi
[28]. In addition to the carboxy-terminal START domain [29]
that binds ceramide, the ER-to-Golgi transfer process requires a
central FFAT domain [30] which binds the ER resident proteins
VAPA and VAPB (Vesicle-associated membrane protein-associat-
ed protein) [31] and an amino-terminal PH domain [32] which
binds PI4P and Arf1 on the Golgi membrane [33,34].
To further investigate the role of CERT in C. trachomatis infection,
we first determined its cellular localization upon infection. In
uninfected cells, the endogenous CERT protein was detected at the
Golgi (Supplementary Figure S1). In C. trachomatis infected cells, the
endogenous CERT protein was highly recruited to C. trachomatis
inclusion as early as 8 h post infection when incoming bacteria had
reached the perinuclear area of the host cells (Figure 1A). As the
infection progressed, the inclusion remained CERT positive
(Figure 1B) and CERT appeared to localize to the inclusion
membrane as shown by co-immuno-staining with the inclusion
membraneprotein,IncA [35,36] (Figure1B). Co-immuno-staining of
C. trachomatis infected cells with antibodies against CERT and the
Golgi markers p115, GM130 or TGN46, did not reveal any co-
localization of the two proteins (Figure 1A and 1C and Supplemen-
tary Figure S1), showing that the CERT signal did not correspond to
the Golgi ministacks surrounding the inclusion in infected cells [9].
However, the CERT signal detected at the inclusion membrane
partly overlapped with the ER resident proteins VAPA (data not
shown) and VAPB (Figure 1D). These results showed that the lipid
transfer protein, CERT, and the ER resident proteins VAPA/B
localize to C. trachomatis inclusion, suggesting a the close apposition of
the ER and the inclusion membrane.
CERT- and VAPB-positive ER tubules are in close
apposition with C. trachomatis inclusion
Localization of the ER resident proteins VAPA and VAPB at
the inclusion membrane and the previous report of ER tracks
Figure 1. CERT and VAPB localize to C. trachomatis inclusion. (A–
C) HeLa cells were infected with C. trachomatis at a high MOI for 8 h to
generate a cluster of incoming bacteria in the perinuclear area of the
cell (A) or at a low MOI for 24 h to generate an inclusion originating
from a single bacterium (B–C). The infected cells were labeled with
antibodies against CERT (CERT, green) (A–C) and the Golgi maker p115
(p115, red) (A, C) or the inclusion membrane protein IncA (IncA, red) (B).
(D) HeLa cells expressing a VAPB-GFP fusion protein (VAPB-GFP, green)
and infected with C. trachomatis for 24 h, were labeled with antibodies
against CERT (CERT, red). The host cell nuclei and the bacterial DNA
were labeled with the DNA dye Hoechst (DNA, blue) (A–D). The merge
images are shown on the right. Scale Bar, 10 mm.
doi:10.1371/journal.ppat.1002092.g001
Author Summary
The obligate intracellular bacterial pathogen Chlamydia
has developed strategies to invade, survive and replicate
within the host genital, ocular and pulmonary epithelial
surfaces. Chlamydia developmental cycle occurs in a
membrane bound vacuole, the inclusion. The Chlamydia-
dependent remodeling of the inclusion membrane leads
to a unique and specialized compartment that allows for
the specific interaction with cellular organelles and the
acquisition of molecules and nutrients required for
bacterial survival and replication. This study provides an
example of how the insertion of C. trachomatis proteins
into the inclusion membrane may allow the bacteria to
manipulate the host cells to its own benefit. We showed
that the lipid transfer protein CERT localized to C.
trachomatis inclusion membrane and partly co-localized
with the endoplasmic reticulum (ER) protein VAPB.
Moreover, VAPB positive tubules made close contact with
the inclusion membrane, suggesting the formation of ER-
Inclusion membrane contact sites upon C. trachomatis
infection. Finally, we have shown that CERT interacted with
the C. trachomatis inclusion protein IncD. We propose that
the presence of CERT, VAPB and IncD at ER-Inclusion
membrane contact sites allow C. trachomatis to exploit the
non-vesicular lipid transport machinery of the host cell and
generate platforms specialized in metabolism and signal-
ing events favorable to bacterial development.
ER-Chlamydia Inclusion Membrane Contact Sites
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membrane [10] led us to further investigate the potential
interaction between the ER and C. trachomatis inclusion at the
ultra structural level.
Electron microscopy analysis of C. trachomatis infected cells
revealed the presence of ER tubules in close proximity of the
inclusion membrane (Figure 2). On the inclusion section depicted
in Figure 2, the ER tubules covered ,25% of the inclusion
membrane (Figure 2A and 2B). The longest tubule was ,2 mm
long (Figure 2B, panel 2) and the shortest tubules were ,250 nm
(Figure 2B, panel 3). Although, the number (1–6) and the size of
the tubules (,250 nm to 2 mm) varied among the inclusion
sections analyzed, all inclusions were to some extent associated
with ER tubules, suggesting a substantial coverage of the inclusion
membrane. The distance between the ER tubules and the
inclusion membrane was ,10 nm (Figure 2C, panels 5 and 6).
We next investigated the cellular localization of CERT and
VAPB with regard to the inclusion membrane and/or the ER
tubules. Cryo-electron microscopy analysis confirmed the presence
of ER tubules in close proximity (,20 nm) of the inclusion
membrane (Figure 3A and 3B). Immunogold labeling showed that
CERT localized to the inclusion membrane and was enriched at
points of contact with the ER tubules (Figure 3A). VAPB was not
observed on the inclusion membrane, but located to the ER
tubules observed in close proximity of the inclusion (Figure 3B).
Altogethertheseresultsareconsistentwiththenotionthat,similar
to the ER-Golgi MCSs observed in non-infected cells [26,27], ER-
Inclusion MCSs are established upon C. trachomatis infection and the
non-vesicular ceramide transfer protein CERT and the ER resident
proteins VAPB localize to these points of contact.
The PH domain of CERT mediates its recruitment to the
inclusion
We next determined the CERT domain required for its
recruitment to the inclusion membrane. As observed with the
endogenous CERT (Figure 1), a CERT-GFP fusion protein
containing the full length CERT was recruited to C. trachomatis
inclusion membrane (Figure 4A, FL-CERT and Supplementary
Figure S2, FL-CERT CTRLsiRNA). Similarly, a construct
containing the PH domain only was also recruited to C. trachomatis
inclusion (Figure 4B, CERT-PH). However, a CERT construct
lacking the PH domain was mostly cytosolic and, except for very
small patches, was no longer recruited to the inclusion membrane
(Figure 4C, CERTDPH and Supplementary Figure S2
CERTDPH CTRLsiRNA). It is likely that, in these experiments,
ER-Inclusion MCSs were formed. Thus, remaining patches
observed in Figure 4C (and Supplementary Figure S2) with the
CERTDPH-GFP construct probably reflected binding of the
fusion protein to the endogenous VAPs through its FFAT domain.
Accordingly, the number of patches was further decreased in
VAPA/B-depleted cells (Supplementary Figure S2 CERTDPH
VAPA&BsiRNA). Altogether, these results indicate that the PH
domain of CERT is necessary and sufficient for CERT association
with C. trachomatis inclusion membrane.
CERT recruitment to the inclusion is Arf1-independent
Our results suggested that, at ER-Inclusion MCSs, CERT
interacted with the ER tubules by binding to the VAPs, and with
the inclusion membrane via its PH domain. The interacting
partner(s) on the inclusion membrane remained however to be
identified. CERT belongs to a family of lipid transfer proteins,
containing OSBP and FAPP [33,37]. These proteins are
characterized by a common amino-terminal PH domain, which
governs their specific association with Golgi membranes. For
OSBP and FAPP, this specificity is conferred by the recognition
and binding of the PH domain to PI4P and Arf1. Both
determinants are simultaneously required since reduced level of
PI4P onto Golgi membrane or Arf1 inactivation reduces the Golgi
association of OSBP and FAPP PH domains [38,39]. Association
of CERT PH domain with Golgi membranes also depends on
PI4P [28,40]. By analogy with OSBP and FAPP, it has been
proposed that Arf1 might also control CERT association with
Golgi membranes [33].
Because Arf1 is present onto the inclusion membrane [41]
(Figure 5, top panels, Arf1-GFP), we tested the functional
importance of Arf1 with respect to CERT recruitment to the
inclusion. As expected, Brefeldin A treatment abolished Arf1
interaction with the inclusion [41] (Figure 5, bottom panels, Arf1-
GFP). However, it did not affect endogenous CERT recruitment
to C. trachomatis inclusion (Figure 5, bottom panels, CERT). We
observed a similar result in Arf1-depleted cells (not shown). These
results suggested that the PH domain of CERT mediates its
recruitment to C. trachomatis inclusion through an Arf1-indepen-
dent mechanism.
The Chlamydia inclusion protein IncD specifically
interacts with the PH domain of CERT
To identify the determinants underlying the recruitment of
CERT to the C. trachomatis inclusion, we performed immuno-
precipitation experiments with extracts obtained from cells
expressing a FLAG-tagged version of CERT. Comparative mass-
spectrometry analyses of uninfected and infected samples led to the
identification of the C. trachomatis effector protein IncD as a potential
binding partner for CERT (see Methods for details and Supple-
mentary Figure S3 for C. trachomatis replication in HEK293 cells).
IncD is theproduct ofthefirstgene of anoperoncontainingthree
other inclusion proteins (IncE, IncF and IncG) [42] and displays a
large centralhydrophobic domain [42,43] (Figure 6A). The IncD-G
operon is expressed within the first two hours of C. trachomatis
developmental cycle and all four proteins were shown to localize to
the inclusion membrane [42]. Both spatial and temporal expression
of IncD made it an attractive candidate for CERT interaction.
We tested the specificity of CERT/IncD interaction by co-
immuno-precipitation experiments. While a CERT-GFP construct
(but not GFP alone) co-immuno-precipitated with the FLAG-
tagged version of IncD (Figure 6B, IP, lanes 1–2), the FLAG-
tagged versions of IncE and IncF, two Inc proteins that had a
cellular localization similar to IncD when over-expressed in
eukaryotic cells (i.e. the ER) (Supplementary Figure S4), did not
(Figure 6C). We next confirmed that CERT/IncD interaction is
mediated through the PH domain of CERT. As expected, a
FLAG-tagged version of IncD co-immunoprecipitated with a
CERT-PH-GFP fusion protein, but did not co-immunoprecipitate
with a CERTDPH-GFP construct lacking the PH domain
(Figure 6B, IP, Lanes 3–4). We confirmed the specificity of IncD
interaction with the PH domain of CERT by showing that the
FLAG-tagged version of IncD failed to co-immunoprecipitate the
phosphoinositide binding domain of FAPP1 [38], p40phox (PX)
[44] or PLCh [45] (Figure 6D). Finally, we confirmed the direct
interaction between IncD and the PH domain of CERT by in vitro
binding assay, using CERT PH domain and IncD purified as MBP
and GST fusion proteins, respectively. As shown in Figure 6E, the
PH domain of CERT interacted strongly with GST-IncD fusion
protein, but not with GST alone. Altogether, these experiments
demonstrated that the C. trachomatis inclusion membrane protein
IncD binds specifically to the PH domain of CERT, suggesting
that IncD is involved in CERT recruitment to the C. trachomatis
inclusion.
ER-Chlamydia Inclusion Membrane Contact Sites
PLoS Pathogens | www.plospathogens.org 3 June 2011 | Volume 7 | Issue 6 | e1002092Figure 2. ER tubules are in close apposition with C. trachomatis inclusion membrane. (A–C) Electron micrographs of HeLa cells infected with
C. trachomatis for 24 h. (A) Low magnification micrograph of the section of an entire inclusion. The black boxes numbered 1 to 4 indicate parts of the
inclusion that make close contact with the ER tubules. (B) Higher magnification micrographs corresponding to the black boxes numbered 1 to 4 in
(A). (C) Close up of the black boxes numbered 5 and 6 in (B) showing the close apposition (,10 nm) of the ER tubules with the inclusion membrane.
N, Nucleus. RB, Chlamydia Reticulate Body. IB, Chlamydia Intermediate Body. White arrowheads, ER tubules. Scale bar, 5 mm (A), 500 nm (B), 250 nm
(C).
doi:10.1371/journal.ppat.1002092.g002
ER-Chlamydia Inclusion Membrane Contact Sites
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membrane
We next investigated IncD localization onto C. trachomatis
inclusion membrane. When C. trachomatis infected cells, were fixed
and permeabilized using paraformaldehyde and saponin, respec-
tively, IncD displayed inclusion membrane localization (Figure 7A,
top panels). However, not all inclusions were IncD positive,
although they were all positive for IncA (Supplementary Figure
S5), suggesting that the IncD antigen was not efficiently revealed.
When the cells were fixed and permeabilized using methanol, all
inclusions were positive for IncA and IncD (Figure 7A, bottom
panels).
We next investigated whether IncD co-localized with CERT
onto the inclusion membrane. When C. trachomatis infected cells
were fixed and permeabilized using paraformaldehyde and
Figure 3. CERT- and VAPB-positive ER tubules are in close apposition with C. trachomatis inclusion. (A–B) Cryo-immunogold electron
micrographs of HeLa cells expressing CERT-GFP (A) or VAPB-GFP (B) fusion proteins and infected with C. trachomatis for 24 h. The sections were
labeled with anti-GFP antibodies coupled to 10 nm gold particles. RB, Chlamydia Reticulate Body. Black arrowheads, Inclusion membrane. White
arrowheads, ER tubule. Scale Bar, 250 nm.
doi:10.1371/journal.ppat.1002092.g003
Figure 4. The PH domain mediates the recruitment of CERT to
the inclusion. HeLa cells expressing CERT-GFP fusion proteins (green),
containing either full-length CERT (FL-CERT) (A) or the PH domain of
CERT only (CERT-PH) (B) or CERT deleted of its PH domain (CERT DPH)
(C), and infected with C. trachomatis for 24 h, were labeled with the
inclusion membrane protein IncA (IncA, red). The DNA dye Hoechst
labeled the host cell nuclei and the bacterial DNA (DNA, blue). The
merge images are shown on the right. Scale Bar, 10 mm.
doi:10.1371/journal.ppat.1002092.g004
Figure 5. CERT recruitment to the inclusion is ARF1-indepen-
dent. HeLa cells expressing Arf1-GFP (ARF1, green) were infected for
24 h with C. trachomatis in the absence (upper panels) or in the
presence of 1 mg/ml BFA (lower panels) and labeled using antibodies
against CERT (red). The DNA dye Hoechst labeled both the nuclei and C.
trachomatis (DNA, blue). The merge images are shown on the right.
Scale Bar, 10 mm. C. trachomatis infection, performed in the presence of
BFA, led to the formation of smaller inclusions as previously reported by
Hackstadt et. al. [12].
doi:10.1371/journal.ppat.1002092.g005
ER-Chlamydia Inclusion Membrane Contact Sites
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membrane (Figure 7B, top panels). As previously observed
(Figure 1), the CERT signal was not homogeneous and appeared
more intense in some areas of the inclusion membrane, some of
which also appeared enriched in IncD (Figure 7B, top panels,
arrowhead). When the cells were fixed with methanol (Figure 7B,
bottom panels), CERT localization was patchier than in
paraformaldehyde-fixed cells and all patches were positive for
both CERT and IncD. Altogether, these results suggested that
IncD and CERT localize to the inclusion membrane and may be
enriched/stabilized at specific macrodomains of the inclusion
membrane.
CERT and VAPA/B depletion impairs C. trachomatis
inclusion development
To demonstrate the physiological relevance of CERT and
VAPA/B recruitment to the C. trachomatis inclusion, we depleted
CERT using two independent pools of CERT siRNA duplexes
and VAPA and VAPB using a combination of pools of VAPA and
VAPB siRNA duplexes. Transfection of the siRNA duplexes
resulted in efficient depletion of all proteins (see Supplementary
Figure S6 for CERT, VAPA and VAPB knock-down efficacy at
the mRNA and protein level and Supplementary Table S1 for
siRNA duplex sequences). In addition, CERT was no longer
detected on the surface of C. trachomatis inclusion in CERT
depleted cells (Supplementary Figure S7). Importantly, these
experiments revealed that C. trachomatis inclusions were smaller in
CERT-depleted cells as compared to control siRNA-treated cells
(Figure 8A and 8B). The overall reduction in inclusion size upon
CERT depletion also correlated with a reduction in infectious
progeny (Figure 8C). Similar to the situation observed with
CERT, depletion of VAPA and VAPB led to the formation of
smaller inclusions (Figure 8A and 8B) and the number of infectious
progeny produced was also reduced (Figure 8C). These experi-
ments confirmed a role for CERT and VAPA/B in C. trachomatis
development.
Figure 6. The Chlamydia inclusion protein, IncD, interacts with the PH domain of CERT. (A) Schematic representation of the incDEFG
operon and the IncD protein. (B) Lysates from HEK293 cells co-expressing 3xFLAG-IncD and the indicated GFP-CERT fusion proteins were
immunoprecipitated with anti-FLAG M2 beads. A portion of the cell lysate (Left Panel, 2% Total) and the immunoprecipitated proteins (Right Panel,
IP) were separated by SDS-PAGE and analyzed by immunoblot with antibodies against GFP (Top Panels) and FLAG (Bottom Panels). (C) Lysates from
HEK293 cells co-expressing 3xFLAG-IncD, 3xFLAG-IncE or 3xFLAG-IncF and GFP-CERT fusion proteins were immunoprecipitated with anti-FLAG M2
beads. A portion of the cell lysate (Right Panel, 2% Total) and the immunoprecipitated proteins (Left Panel, IP) were separated by SDS-PAGE and
analyzed by immunoblot with antibodies against GFP (Top Panels) and FLAG (Bottom Panels). (D) Lysates from HEK293 cells co-expressing 3xFLAG-
IncD and the indicated GFP or YFP fusion proteins were immunoprecipitated with anti-FLAG M2 beads. A portion of the cell lysate (Right Panel, 2%
Total) and the immunoprecipitated proteins (Left Panel, IP) were separated by SDS-PAGE and analyzed by immunoblot with antibodies against GFP
(Top Panels) and FLAG (Bottom Panels). (E) The indicated GST fusion proteins, immobilized onto glutathione sepharose were incubated in the
presence of the indicated purified MBP fusion proteins. The protein complexes bound to the resin were separated by SDS-PAGE and analyzed by
immunoblot with antibodies against MBP (Top Panels) and GST (Bottom Panels). The inputs for each purified protein are shown in the right panels
(Input).
doi:10.1371/journal.ppat.1002092.g006
ER-Chlamydia Inclusion Membrane Contact Sites
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CERT and VAPA/B recruitment to C. trachomatis inclusion
We showed that the lipid transfer protein, CERT, was recruited
to C. trachomatis inclusion (Figure 1 and Figure 4A). The CERT
signal was not evenly distributed onto the inclusion and appeared
more concentrated in some areas. Although CERT localizes to
Golgi membranes in uninfected cells, the CERT signal observed
upon infection did not correspond to the Golgi ministacks
surrounding the inclusion in infected cells [9], but rather
corresponded to the inclusion membrane. These data indicate
that CERT is enriched in some macrodomains of the inclusion
membrane.
Our results also showed that the ER resident proteins, VAPA
and VAPB, were recruited to C. trachomatis inclusion in areas
enriched in CERT (Figure 1). VAPB however did not localized to
the inclusion membrane but rather to ER tubules that were in
close proximity of the inclusion membrane (Figure 3), suggesting a
potential interaction between the ER and the inclusion.
ER-Inclusion MCSs
Many cellular organelles have been shown in close apposition to
or interacting with the Chlamydia inclusion, including the Golgi [9],
mitochondria [46], multivesicular bodies [13] and lipid droplets
[17]. Tracks of ER have also been reported in the proximity of C.
trachomatis inclusion [10]. Our electron microscopy analysis
(Figure 2 and Figure 3) is in agreement with this latest observation,
since it revealed the close apposition of ER tubules to C. trachomatis
inclusion and therefore suggests a direct interaction between the
ER and the inclusion through the formation of ER-Inclusion
MCSs.
MCSs are defined as a zone of close apposition (10–50 nm)
between two organelles. In eukaryotes, the ER has been described
as one of the partnering organelle and has been shown to make
close contact with the yeast vacuole, the plasma membrane, the
Golgi complex, endosomes and lysosomes, and mitochondria.
Except for the yeast ER/Vacuole MCSs [47], bridging complexes,
also referred to as structural components, that bring the two
partnering membranes in close apposition and stabilize of MCSs,
have not been identified. In contrast, an increasing number of
proteins known to function on two contacting organelles have
been identified and are referred as functional components [26,27],
including CERT, which is proposed to be a functional component
of ER-Golgi MCSs.
The distance between the ER tubules and C. trachomatis
inclusion membrane was 10–20 nm (Figure 2 and Figure 3),
which is in agreement with the notion of ER-Inclusion MCSs. We
cannot exclude that, as described for the yeast ER/Vacuole MCSs
[47], specific structural components are involved in the formation
and maintenance of the ER-Inclusion MCSs. These factors could
be of mammalian and/or bacterial origin. Our results however
indicate that, CERT, a previously proposed functional component
of ER-Golgi MCSs, is probably also a functional component of
ER-Inclusion MCSs.
Role of Arf1 and PI4P in CERT association with
C. trachomatis inclusion membrane
CERT belongs to a family of lipid transfer proteins, containing
OSBP and FAPP [33,37]. These proteins are characterized by a
common amino-terminal PH domain, which governs their specific
association with Golgi membranes by recognizing and binding to
PI4P (OSBP, FAPP and CERT) and Arf1 (OSBP and CERT). By
analogy with OSBP and FAPP, it has been proposed that Arf1
might also control CERT association with Golgi membranes [33].
Because Arf1 and PI4P are also present at the inclusion membrane
[41], it made them likely components involved in CERT
recruitment to C. trachomatis inclusion membrane.
Moorhead et. al. study showed that OSBP-PH and CERT-PH
(referred as GPBP in this study) associated with Chlamydia inclusion
membrane. However, the association was not sensitive to Brefeldin
A, suggesting that it was Arf1-independent. In agreement, we
showed that Brefeldin A or Arf1 depletion did not affect
endogenous CERT association with the inclusion membrane
(Figure 5), confirming that Arf1 is not involved in this process.
Moorhead et. al. showed that the association of OSBP-PH with
the inclusion membrane was however sensitive to a mutation in
OSBP-PH domain that abolished PI4P binding (but not Arf1
binding). This result led the author to conclude that the
localization of PI4P-binding PH domains to the inclusion reflected
the presence of PI4P at the inclusion membrane. We have
attempted to confirm the involvement of PI4P in the endogenous
CERT association with the inclusion by depleting enzyme
involved in PI4P synthesis. PI4KIIIß has been identified as the
main source of PI4P on Golgi membranes and therefore a key
regulator of CERT, OSBP and FAPP association with Golgi
membrane [33,37]. Moorhead et. al. have proposed that OCRL1
and PI4KIIa might contribute to the pool of Chlamydia inclusion
membrane PI4P [41]. Treatment with a specific PI4KIIIß
Figure 7. IncD co-localizes with CERT onto C. trachomatis inclusion membrane. (A–B) HeLa cells infected with C. trachomatis for 24 h were
fixed and permeabilized using 4% PFA and Saponin, respectively, (PFA-Sap., top panels) or Methanol (MetOH, bottom panels) and labeled with
antibodies against the inclusion membrane protein IncD (IncD, green) (A–B) and the inclusion membrane protein IncA (IncA, red) (A) or CERT (CERT,
red) (B). The host cell nuclei and the bacterial DNA were labeled with the DNA dye Hoechst (DNA, blue). The merge images are shown on the right.
The arrowheads indicate an area of the inclusion membrane enriched in CERT and IncD. Scale Bar, 10 mm.
doi:10.1371/journal.ppat.1002092.g007
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proteins had no effect on CERT recruitment to C. trachomatis
inclusion (not shown). Altogether, these results left open the role of
PI4P in CERT association with the C. trachomatis inclusion
membrane.
Role of IncD in CERT recruitment to the inclusion
membrane
We have identified the C. trachomatis inclusion membrane
protein IncD as an in vivo binding partner of CERT and we
showed that IncD interacted with the PH domain of CERT
(Figure 6). This interaction was highly specific because IncD did
not interact with other phosphoinositide-binding domain and
CERT did not interact with other Inc proteins (i.e. IncE or IncF).
Our results therefore suggested a role for IncD in the association of
CERT with the inclusion membrane.
In agreement with this notion, both IncD and CERT localized
to C. trachomatis inclusion membrane (Figure 7). Various methods
of fixation suggested that IncD and CERT displayed partial co-
localization into patches. In addition, CERT appeared enriched in
some areas that were in contact with VAPB positive tubules
(Figure 1). These data suggest that the enrichment of CERT and
IncD onto macrodomains of the inclusion membrane may
correspond to the point of contacts with the ER where IncD/
CERT/VAPB form a complex through the binding of CERT to
IncD onto the inclusion membrane and to VAPB onto the ER
tubules. Further characterization of IncD/CERT/VAPB interac-
tion will be required to identify the determinants that drive the
specific formation of this complex.
Altogether, our results suggest that C. trachomatis has evolved
strategies to efficiently hijack CERT and relocate it to the
inclusion membrane. Unfortunately, because genetic tools are not
available to manipulate Chlamydia, we were not able to assay
whether a C. trachomatis IncD mutant is impaired in CERT
localization to the inclusion and whether its developmental cycle is
perturbed. We were however able to show that C. caviae, a strain of
Chlamydia that infect guinea pigs and that is lacking IncD, was not
able to recruit CERT-GFP to its inclusion membrane (Supple-
mentary Figure S8), confirming the specific role of IncD in CERT
recruitment to the inclusion.
Although our in vitro binding study demonstrated that IncD
interact with the PH domain of CERT in the absence of additional
factors (Figure 6), we cannot exclude the involvement of additional
host or C. trachomatis factors in vivo, including PI4P. If PI4P plays a
role in CERT association with the inclusion membrane, it would
be interesting to determine whether the analogy could be made
between PI4P/Arf1 on Golgi membranes and PI4P/IncD on C.
trachomatis inclusion membrane. On the other hand, if PI4P is not
required for CERT association with C. trachomatis inclusion
membrane, it would suggest that IncD may mimic the Arf1/
PI4P determinants that usually drive CERT recruitment to Golgi
membranes. We also note that IncD could act in concert with
some yet to be discovered host and/or bacterial factors that
localize at the inclusion membrane. Further structure/function
analyses of IncD will be required to address these questions.
CERT and VAPA/B depletion and Chlamydia development
Our results showed that CERT or VAPA/B depletion was
detrimental to C. trachomatis development (Figure 8), but the
specific role of these proteins remains to be determined. Previous
studies have shown that sphingomyelin-containing vesicles traffic
from the Golgi ministacks that surround the inclusion, to the
inclusion, where sphingomyelin is incorporated into the inclusion
membrane as well as the cell wall of the bacteria. It was also shown
Figure 8. CERT and VAPA/B depletion impairs C. trachomatis
inclusion development. HeLa cells were transfected with control
siRNA (GFPsi) or two different pool of CERT siRNA (CERTsi1 and CERTsi2)
or a pool of siRNA against VAPA and VAPB (VAPA&Bsi) for 3 days and
infected with C. trachomatis for 32 h. (A) Immunofluorescence images
to illustrate the difference in inclusion size between control (GFPsi) and
CERT- (CERTsi1) or VAPA/B- (VAPA&Bsi) depleted cells. The cells were
fixed and labeled with an antibody against C. trachomatis (Chlamydia,
green). The DNA dye Hoechst labeled the host cell nuclei and the
bacterial DNA (DNA, red). The merge images are shown on the right.
Scale Bar, 10 mm. (B) For each condition, the surface area of 300
inclusions was determined. Each point represents data from a single
inclusion. The grey lines indicate the mean values from the data for
each condition. The difference between control and CERT or VAPA&B
siRNA was statistically significant; ***P,0.0001 (Student’s t test). (C) The
number of infectious bacteria measured as IFUs/ml was determined
48 h p.i.. Data show the mean and standard deviation of triplicates of a
representative experiment.
doi:10.1371/journal.ppat.1002092.g008
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development [9,12,48–50]. Since CERT is involved in the non-
vesicular trafficking of the sphingomyelin precursor ceramide from
the ER to the Golgi, an overall defect in sphingomyelin synthesis
could explain the defect in C. trachomatis development observed in
CERT-depleted cells.
Although we did not measure sphingomyelin synthesis in CERT
siRNA-treated cells, studies from the Hanada group using the LY-
A cell line (in which CERT is inactive due to a mutation in the PH
domain that prevents CERT association with Golgi membranes)
and fluorescent ceramide or [
3H]sphingosine, revealed that the
LY-A cell line showed at least a 50% reduction in sphingomyelin
biosynthesis [28,51], supporting the hypothesis that CERT
siRNA-treated cells might have reduced level of sphingomyelin.
These studies however also suggested the existence of a CERT-
independent pathway for sphingomyelin synthesis that could
account for up to 50% of sphingomyelin synthesis.
We did not observe any major disruption of the Golgi
morphology in CERT- or VAPA/B-depleted cells (Supplementary
Figure S9) and 60% of the inclusions had detectable Golgi
ministacks around them in both control and CERT depleted cells,
suggesting that the Golgi fragmentation necessary for optimal
sphingomyelin acquisition was not impaired. When infected cells
were labeled with fluorescent ceramide, which is subsequently
metabolized into sphingomyelin in the Golgi, and incorporated into
the inclusion [12,48,49], we observed the accumulation of
fluorescent lipids at the Golgi and in C. trachomatis inclusion from
control or CERT- or VAPA/B-depleted cells (Supplementary
Figure S10, S11, S12 and S13). These results suggested that lipids
were still trafficked to the inclusion in CERT siRNA-treated cells
and it is most likely that, in the context of CERT siRNA-treated
cells, the CERT-independent pathway of ceramide trafficking from
the ER to the Golgi, explain the labeling of the Golgi. Labeling of
the inclusion could then occur through vesicular trafficking of
sphingomyelin from the Golgi as previously described [12,48,49].
If both CERT-dependent and –independent pathways participate
to the accumulation of fluorescent lipids in the inclusion, one could
expect a reduction in fluorescence in CERT siRNA-treated cells.
The rapid bleaching of the fluorescent signal of BODIPY-C5-
Ceramide, however did not allow us to accurately quantify the
fluorescence intensity of the inclusions. Another limitation of this
assayisthatitdoesnotdeterminethenatureofthefluorescentlipid(s)
that accumulate in the inclusion. Additional experiments involving
lipid extraction and analysis will be required to unambiguously
determine the nature of the fluorescent lipid(s) that we observed in
the inclusion in CERT- VAPA/B siRNA-treated cells.
Altogether, it is possible that a partial overall reduction in host
cell sphingomyelin explains the partial reduction in C. trachomatis
growth observed in CERT siRNA treated cells, however further
experiments, including the uncoupling of CERT-dependent and –
independent pathways, are required to unequivocally address this
question.
Given the localization of CERT to the inclusion, the described
role of CERT in ceramide transfer and the presence of ER tubules
(source of ceramide) in close apposition with the inclusion
membrane, we favor the idea that CERT transfers ceramide
from the ER to the inclusion membrane. Because of the
requirement of Chlamydia for sphingomyelin for replication,
ceramide could serve as a precursor for sphingomyelin synthesis
directly at the inclusion membrane, assuming that a sphingomy-
elin synthase of host or bacterial origin is also present at the
inclusion membrane. Alternately, it is possible that ceramide
accumulates at the inclusion without being further modified and
serves as a signaling molecule at the inclusion membrane. For
example, it has been proposed that the lipid transfer/binding
proteins (LT/BPs) Nir2 [52] and OSBP [53], which are
respectively involved in the non-vesicular transfer of phosphatidy-
linositol/phosphatidylcholine (PI/PC) and sterols at ER-Golgi
MCSs, act together with CERT to affect the lipid composition of
the Golgi membranes and therefore influence the structural and
functional identities of these membranes [54]. Similarly, the
CERT-dependent transfer of ceramide at ER-Inclusion MCSs
could influence the lipid composition of the inclusion membrane
and generate specialized metabolic and/or signaling microenvi-
ronment favorable for bacterial development. Whether other LT/
BPs, such as Nir2 or OSBP, or additional host factors localize to
ER-Inclusion MCSs and participate in the formation of these
specialized platforms remain to be determined. Finally, we cannot
exclude that CERT has a yet to be discovered role at the inclusion
membrane that does not involve ceramide transport.
Conclusion
Altogether our results suggest a model in which the C. trachomatis
effector protein IncD specifically interacts with the non-vesicular
ceramide transfer protein CERT, at MCSs between C. trachomatis
inclusion membrane and ER tubules harboring the VAPA/B
proteins (Figure 9). We speculate that the IncD-CERT-VAPA/B
interaction may be involved in the non-vesicular transfer of
ceramide from the ER to the inclusion. We however cannot
exclude a more complex role for ER-Inclusion MCSs in
supporting bacterial development. Further studies of the ER-
Inclusion MCSs, including the identification of additional
structural and functional components, may not only reveal the
mechanisms underlying C. trachomatis pathogenesis, but may also
illuminate the poorly understood cellular mechanisms underlying
inter-organelle communication.
Materials and Methods
Cell lines and bacterial strains
HeLa cells and HEK293 cells (ATCC) and HeLa229 cells
(Dautry-Varsat Laboratory, Pasteur Institute, Paris, France) were
cultured at 37uC with 5% CO2 in DMEM high glucose
(Invitrogen) supplemented with 10% heat inactivated FBS
(Invitrogen). C. trachomatis Lymphogranuloma venereum, Type II were
obtained from ATCC (L2/434/Bu VR-902B). C. caviae was
obtained from the Dautry-Varsat Laboratory (Pasteur Institute,
Paris, France) and was originally from Roger Rank Laboratory
(Little Rock, Arkansas). Chlamydia propagation and infection was
performed as previously described [55].
siRNA and DNA transfection
The protocol used for siRNA transfection was adapted from
Dharmacon HeLa cells transfection’s protocol (www.dharmacon.
com) [55]. The sequences of the siRNA duplexes used in this study
are described in Supplementary Table S1. DNA transfection was
performed using Fugene 6 according to the manufacturer
recommendations. DNA transfection of siRNA treated cells was
performed 2 days post siRNA transfection.
Quantitative PCR
Total RNA and first-strand cDNA synthesis was performed
using the TaqMan Gene Expression Cells-to-Ct Kit (Applied
Biosystems) as recommended by the manufacturer with the
addition of DNaseI for the removal of unwanted genomic DNA.
mRNA levels were determined by quantitative real-time PCR
using the LightCycler 480 Master Kit and LightCycler 480
instrument (Roche Biochemicals, Indianapolis, IN). The combi-
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relative amount of target mRNA by quantitative PCR is described
in Supplementary Table S2.
DNA constructs
The PH domain of CERT, VAPA and VAPB ORFs were
amplified from HeLa cell cDNA. The ORF corresponding to full
length CERT was amplified from a myc-CERT construct [56].
IncD, IncE and IncF ORFs were amplified from C. trachomatis
genomic DNA. The primers and vectors used in this study are
described in Supplementary Table S3. Arf1-GFP [57] and PX-
YFP [44] were described previously.
Immunoblotting
Protein samples were separated by SDS-PAGE and analyzed by
immunoblot using HRP-conjugated secondary antibodies and
Amersham ECL western blotting detection reagents.
Immunofluorescence and microscopy
At the indicated time, the cells seeded onto glass coverslips were
fixed for 30 min in PBS containing 4% paraformaldehyde.
Immunostaining were performed at room temperature. Antibodies
were diluted in PBS containing 0.16 mg/ml Hoechst (Molecular
Probes), 0.1% BSA and 0.05% Saponin. Samples were washed with
PBS containing 0.05% Saponin and a final PBS wash was
performed before examination under an epifluorescence micro-
scope. Samples presented in the lower panels of Figure 7 were fixed
in ice-cold methanol for 5 min and labeled with antibodies diluted
in PBS containing 0.1% BSA. Images presented in Supplementary
Figure 2 were acquired using a confocal microscope.
Antibodies
The following primary antibodies were used: rabbit polyclonal
anti-C. trachomatis (1:300 (IF), Virostat), rabbit polyclonal anti-C.
trachomatis IncA (1:200 (IF), kindly provided by T. Hackstadt,
Rocky Mountain Laboratories), rabbit polyclonal anti-C. caviae
IncA (1:300 (IF), kindly provided by A. Subtil, Pasteur Institute,
Paris, France), mouse polyclonal anti-C. trachomatis IncD (1:300
(IF), kindly provided by G. Zhong, University of Texas Health
Science Center at San Antonio), chicken polyclonal anti-CERT
(1:200 (IF), 1:1,000 (WB) Sigma), mouse anti-p115 (1:200 (IF),
kindly provided by G. Waters), mouse anti-GM130 (1:200 (IF), BD
Transduction Lab.), sheep anti-TGN46 (1:200 (IF), Serotec),
rabbit polyclonal anti-GFP (1:200 (EM), 1:2,000 (WB), Invitrogen),
mouse anti-FLAG (1:20,000 (WB), Sigma), rabbit polyclonal anti-
VAPB (1:200 (WB), Abcam), rabbit polyclonal anti-actin (1:10,000
(WB), Sigma).
The following secondary antibodies were used: goat anti-rabbit
AlexaFluor 594 antibody (1:500, Molecular Probes), goat anti-
mouse AlexaFluor 594 antibody (1:500, Molecular Probes),
donkey anti-sheep AlexaFluor 594 antibody (1:500, Molecular
Probes), Fluorescein (FITC) donkey anti-chicken IgY antibody
(1:300, Jackson ImmunoResearch), peroxidase-conjugated goat
anti-rabbit IgG (1:10,000, Jackson ImmunoResearch), peroxidase-
conjugated goat anti-mouse IgG (1:10,000, Jackson ImmunoR-
esearch), peroxidase-conjugated donkey anti-chicken IgY
(1:10,000, Pierce).
Electron microscopy
HeLa cells seeded onto glass coverslips and infected with C.
trachomatis for 24 h were fixed in 2.5% glutaraldehyde in 0.1 M
sodium cacodylate buffer pH 7.4 with 2% sucrose for 1 hour. The
samples were rinsed 3 times in sodium cacodylate buffer then were
postfixed in 1% osmium tetroxide for 1 hour, en bloc stained in
2% uranyl acetate in maleate buffer pH 5.2 for a further hour then
rinsed, dehydrated in an ethanol series and infiltrated with epon
resin. The coverslips were then covered with resin filled capsules
and baked over night at 60uC. Hardened block enface sections
were cut using a Leica UltraCut UCT. 60 nm sections were
collected and stained using 2% uranyl acetate and lead citrate.
Samples were all viewed FEI Tencai Biotwin TEM at 80 Kv.
Images were taken using Morada CCD and iTEM (Olympus)
software.
Immuno electron microscopy
HeLa cells were transfected with a GFP-CERT or GFP-VAPB
construct for 18 h and infected with C. trachomatis for an additional
24 h. The cells were washed with PBS, fixed in PBS containing
4% Paraformaldehyde/0.1% Glutaraldehyde for 15 min at room
temperature, followed by 45 min at 4uC in 4% paraformaldehyde
and re-suspended in 10% gelatin. Trimmed smaller blocks were
placed in 2.3 M sucrose overnight on a rotor at 4uC. Then
transferred to aluminum pins and frozen rapidly in liquid nitrogen.
The frozen block were trimmed on a Leica Cryo-EMUC6
UltraCut and 65 nm thick sections were collected using the
Tokoyasu method [58], placed on a nickel formvar/carbon coated
grid and floated in a dish of PBS ready for immunolabeling. For
immunolabeling of the sections, the grids were placed section side
down on drops of 0.1 M ammonium chloride to quench untreated
aldehyde groups, then blocked for nonspecific binding on 1% fish
skin gelatin in PBS. Grids were incubated on a primary antibody
rabbit anti-GFP. The grids were then placed on protein A gold
10 nm (UtrechtUMC). All grids were rinsed in PBS between steps,
lightly fixed using 1% glutaraldehyde, rinsed and transferred to a
UA/methylcellulose drop, then collected and dried. Grids were
viewed in FEI Tencai Biotwin TEM at 80 Kv. Images were taken
using Morada CCD and iTEM (Olympus) software.
Figure 9. Schematic representation of ER-Chlamydia inclusion
membrane contact sites. ER-Inclusion membrane contact sites are
formed upon Chlamydia infection. These sites are enriched for the
ceramide transfer protein CERT. CERT contacts the ER by binding to
VAPA/VAPB and interacts with IncD onto the inclusion membrane,
through its PH domain. The close apposition of ER tubules to the
inclusion membrane may produce a dynamic environment specialized
in non-vesicular trafficking of lipids, such as ceramide, leading to
metabolism and signaling events that will ensure proper bacterial
development.
doi:10.1371/journal.ppat.1002092.g009
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Lysates from HEK293 transfected with a 3xFLAG-CERT
construct for 18 h and infected with C. trachomatis for an additional
24 hwereimmunoprecipitatedusinganti-FLAGM2agarose beads.
Thebound proteinswereseparatedbySDS-PAGEandanalyzed by
Silver Nitrate staining. A ,15 kDa band present in the transfected/
infected samples but not in the transfected or infected only samples
was analyzed by LC MS-MS at the Yale W.M. Keck laboratory.
Co-Immunoprecipitation
5.10
5 HEK293 cells plated in 6-well tissue culture dishes and
transfected for 48 h were washed once with 16PBS and lyzed for
30 min in300 mloflysisbuffer(20 mMTrispH 7.5,150 mMNaCl,
2 mM EDTA, 1%Triton X-100, 1 mM PMSF and protease
inhibitor cocktail (Roche)). The lysates were centrifuge at
13,000 rpm for 10 min. An aliquot of the clarified lysate was
collected (Input). The clarified lysates were incubated for 2 h in the
presence of 10 ml of anti-FLAG M2 agarose beads (Sigma). The
beads were washed 3 times (20 mM Tris pH 7.5, 150 mM NaCl,
2 mMEDTA, 1%Triton X-100) and the bound proteins wereeluted
with 15 ml of elution buffer (20 mM Tris pH 7.5, 150 mM NaCl,
2 mM EDTA, 100 mg/ml 3XFLAG peptide (Sigma)). 10 mlo ft h e
eluted fraction was collected (IP). All steps were conducted at 4uC.
Protein purification
MBP and MBP-CERT PH were expressed in E. coli (BL2lDE3).
The bacteria were resuspended in lysis buffer (20 mM Tris
pH 7.5, 300 mM NaCl, 2 mM EDTA, 1 mM MgCl2, 1% Triton
X-100, 1 mM DTT and 1 mM PMSF) and lysed by sonication.
The clarified lysates were incubated for 2 h in the presence of
amylose resin (NEB). The resin was washed 3 times with 20 mM
Tris pH 7.5, 300 mM NaCl, 1 mM MgCl2. The bound proteins
were eluted by incubation with 20 mM Tris pH 7.5, 100 mM
NaCl, 1 mM MgCl2, 30 mM Gluthathione, dialysed over night in
20 mM Tris pH 7.5, 100 mM NaCl, 1 mM MgCl2 and stored in
small aliquots at 220uC. GST and GST-IncD were prepared as
described above and bound to glutathione sepharose beads (GE
Healthcare). All steps were conducted at 4uC.
In vitro binding assay
Equal amounts of freshly purified GST fusion proteins bound to
glutathione beads were incubated with 0.2 mM of the indicated
MBP fusion proteins in binding buffer (20 mM Tris pH 7.5,
150 mM NaCl, 1 mM MgCl2, 0.2% Triton X-100) for 2 h at 4uC,
washed 3 times with 20 mM Tris pH 7.5, 300 mM NaCl, 1 mM
MgCl2, 0.2% Triton X-100 and Laemli buffer, separated by SDS-
PAGE and analyzed by immunoblot.
Inclusion size quantification and computer-assisted
image analysis
siRNAtreated cellswereinfectedwithC.trachomatisfor36 hrs.The
nuclei and the bacteria were labeled with the DNA dye Hoechst and
the inclusions were counter-stained with a rabbit polyclonal antibody
against C. trachomatis and a goat anti-rabbit AlexaFluor 594 antibody.
The cells were subjected to automated fluorescence microscopy to
capture images corresponding to the cell nuclei and the inclusion.
Computer-assisted image analysis, using the analytical tools of the
Metamorph software, was used to determine the number of nuclei
and the surface area of each inclusion.
Infectious progeny production
HeLa cells incubated with the indicated siRNA duplexes for 3
days were collected 48 h post infection, lysed with glass beads and
dilutions of the lysate were used to infect fresh HeLa cells. The
cells were fixed 24 h post infection and the number of inclusion
forming units (IFUs) was determined after assessment of the
number of infected cells by immonolabelling.
BODIPYFL-C5-Ceramide labeling
Control and siRNA treated C. trachomatis-infected HeLa cells
seeded onto glass coverslips were washed three times with cold
Hank’s Balanced Salt Solution (HBSS, Invitrogen) and incubated
in DMEM containing 2.5 mM DFBSA/BODIPYFL-C5-Cer-
amide (Invitrogen) and 5 mg/ml Hoechst for 30 min at 4uC.
The cells were then washed three times with cold HBSS and
incubated in DMEM containing 0.34% DFBSA (Calbiochem) at
37uC in the presence of 5% CO2. Pictures of the live cells were
acquired in the FITC and DAPI channel with a 106 objective
every 15 min after the beginning of the chase.
Accession numbers
The accession numbers for C. trachomatis (L2/434/Bu) proteins
are IncD (CTL0370): CAP03810.1, IncE (CTL0371): CAP03811.1
and IncF (CTL0372): CAP03812.1.
The accession numbers for the mammalian genes are CERT
(isoform 2): NM_031361.2, VAPA (isoform 2): NM_194434.2, VAPB:
NM_004738.4, ARF1: NM_001024227, PI4KIIIß: NM_002651.1,
OCRL1: NM_000276.3 and PI4KIIa: NM_018425.2.
Supporting Information
Figure S1 CERT localizes to the Golgi in uninfected
cells but not in C. trachomatis infected cells. (A–C) HeLa
cells left uninfected (Uninfected) or infected with C. trachomatis for
24 h (C. trachomatis) were labeled with antibodies against CERT
(CERT, green) (A–C) and the Golgi makers GM130 (GM130, red)
(A), p115 (p115, red) (B) or TGN46 (TGN46, red) (C). The host
cell nuclei and the bacterial DNA were labeled with the DNA dye
Hoechst (DNA, blue). The merge images are shown in the right
panels. Scale Bar, 10 mm.
(TIF)
Figure S2 Inclusion localization of full length CERT or
CERT depleted of its PH domain in control or VAPA/B-
depleted cells. Extended focus images, created from a stack of
serial z-sections from HeLa cells depleted or not from VAPA&B
(VAPA&B siRNA, bottom panels and CTRL siRNA, top and
middle panels, respectively) expressing CERT-GFP fusion proteins
(green), containing either full-length CERT (FL-CERT, top panels)
or CERT deleted of its PH domain (CERT DPH, middle and
bottom panels) and infected with C. trachomatis for 24 h. The cells
were labeled with the inclusion membrane protein IncA (IncA, red).
The merge images are shown on the right. Scale Bar, 10 mm.
(TIF)
Figure S3 C. trachomatis infection of HEK293 cells.
HEK293 cells infected with C. trachomatis for 24 h were fixed and
stained with anti-IncA antibodies (A) or anti-CERT antibodies (B).
The DNA dye Hoechst labeled the host cell nuclei and the
bacterial DNA (DNA, red). The merge images are shown on the
right. Scale Bar, 50 mm. The replication of Chlamydia in HEK293
is comparable to replication in HeLa cells. Large inclusions are
formed and both IncA and CERT localize to the inclusion
membrane.
(TIF)
Figure S4 Cellular localization of 3xFLAG-IncD,
3xFLAG -IncE and 3xFLAG –IncF. HeLa cells expressing
3xFLAG-IncD (IncD, green), 3xFLAG-IncE (IncE, green) or
ER-Chlamydia Inclusion Membrane Contact Sites
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the FLAG peptide (3xFLAG-Inc, green) and the ER protein
Calnexin (Calnexin, red). The DNA dye Hoechst labeled the host
cell nuclei (DNA, blue). The merge images are shown on the right.
Scale Bar, 10 mm.
(TIF)
Figure S5 IncD immuno-labeling of infected cells after
fixation and permeabilization using 4%PFA and sapo-
nin, respectively. HeLa cells infected with C. trachomatis for
24 h were fixed and permeabilized using 4% PFA and Saponin,
respectively, and labeled with antibodies against the inclusion
membrane protein IncD (IncD, green) and the inclusion
membrane protein IncA (IncA, red). The host cell nuclei and
the bacterial DNA were labeled with the DNA dye Hoechst
(DNA, blue). The merge image is shown on the right. The
asterisk indicates an IncD/IncA positive inclusion. The arrow-
heads indicate IncD negative, IncA positive inclusions. Scale Bar,
20 mm.
(TIF)
Figure S6 Efficacy of CERT and VAPA and VAPB knock-
down. HeLa cells were transfected with control siRNA (GFPsi) or
two different pools of CERT siRNA (CERTsi1 and CERTsi2) or a
pool of siRNA against VAPA and VAPB (VAPA&Bsi) for 3 days.
The silencing efficiency was evaluated at the transcript level by
quantitative PCR (A) or at the protein level by western blot (B).
(TIF)
Figure S7 CERT is no longer detected onto C. tracho-
matis inclusion in CERT-depleted cells. HeLa cells
transfected with control siRNA (GFPsi) or CERT siRNA
(CERTsi1) or a pool of siRNA against VAPA and VAPB
(VAPA&Bsi) for 3 days and infected with C. trachomatis for 24 h
were labeled with antibodies against CERT (CERT, green). The
host cell nuclei and the bacterial DNA were labeled with the DNA
dye Hoechst (DNA, blue). The merge images are shown on the
right. Scale Bar, 10 mm.
(TIF)
Figure S8 CERT-GFP localization in C. trachomatis or
C. caviae infected cells. HeLa 229 cells expressing the CERT-
GFP fusion protein (green) and infected with C. trachomatis (Top
panels) or C. caviae (Bottom panels) for 24 h, were labeled with
antibodies against the inclusion membrane protein IncA (IncA,
red). The DNA dye Hoechst labeled the host cell nuclei and the
bacterial DNA (DNA, blue). The merge images are shown on the
right. Scale Bar, 10 mm.
(TIF)
Figure S9 Golgi morphology of control, CERT- or
VAPA/B-depleted cells. HeLa cells, transfected with control
siRNA (CTRL) or a pool of CERT siRNA (CERTsi) or a pool of
siRNA against VAPA and VAPB (VAPA&Bsi) for 3 days, were
labeled with antibodies against the Golgi maker GM130 (GM130,
green). The host cell nuclei were labeled with the DNA dye
Hoechst (DNA, blue). The merge images are shown in the right
panels. Scale Bar, 10 mm.
(TIF)
Figure S10 BODIPYFL-C5-Ceramide labeling of control
cells infected with C. trachomatis. HeLa cells transfected
with control siRNA for 3 days and infected with C. trachomatis for
28 h were labeled with BODIPYFL-C5-Ceramide and Hoechst.
The ceramide was chased for the indicated time and pictures were
acquired in the DAPI (DNA, red) and FITC (BODIPYFL-C5-
Ceramide, green) channels. The merge images are shown in the
bottom panels. Asterisks indicate C. trachomatis inclusions. Scale
Bar, 10 mm.
(TIF)
Figure S11 BODIPYFL-C5-Ceramide labeling of CERT-
depleted cells infected with C. trachomatis. HeLa cells
transfected with CERT siRNA for 3 days and infected with C.
trachomatis for 28 h were labeled with BODIPYFL-C5-Ceramide
and Hoechst. The ceramide was chased for the indicated time and
pictures were acquired in the DAPI (DNA, red) and FITC
(BODIPYFL-C5-Ceramide, green) channels. The merge images
are shown in the bottom panels. Asterisks indicate C. trachomatis
inclusions. Scale Bar, 10 mm.
(TIF)
Figure S12 BODIPYFL-C5-Ceramide labeling of VA-
PA&B- depleted cells infected with C. trachomatis. HeLa
cells transfected with VAPA&B siRNA for 3 days and infected
with C. trachomatis for 28 h were labeled with BODIPYFL-C5-
Ceramide and Hoechst. The ceramide was chased for the
indicated time and pictures were acquired in the DAPI (DNA,
red) and FITC (BODIPYFL-C5-Ceramide, green) channels. The
merge images are shown in the bottom panels. Asterisks indicate
C. trachomatis inclusions. Scale Bar, 10 mm.
(TIF)
Figure S13 Comparison of BODIPYFL-C5-Ceramide
labeling of control cells, CERT-depleted cells and
VAPA&B-depleted cells infected with C. trachomatis.
Images of representative inclusions shown in Supplementary
Figures S10 (Control), S11 (CERT siRNA) and S12 (VAPA&B
siRNA). DNA: Red, BODIPYFL-C5-Ceramide: Green. Asterisks
indicate C. trachomatis inclusions. Scale Bar, 10 mm.
(TIF)
Table S1 Sequence of the siRNA duplexes used in this
study.
(DOC)
Table S2 Probes and Primers used for the quantitative
PCR. The probes and primers were designed according to Roche
recommendation: http://www.roche-applied-science.com/sis/rtpcr/
upl/index.jsp?id=uplct_030000.
(DOC)
Table S3 Plasmids constructed for this study. The
following plasmids were constructed for this study. The table
indicates the name of the inserts, the vectors and the restriction
sites in which they were cloned into, and the sequences of the
primers.
(DOC)
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